Big data accelerates the pace of breast cancer drug development by enabling researchers to analyze vast amounts of information on molecular biology and the genetic basis of cancer. This comprehensive analysis helps identify potential drug targets more efficiently, reduces the time and cost associated with clinical trials, and speeds up the process of bringing new, effective drugs to market.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.